AMEX Biotechnology Index (BTK)

Click here for current quotes of index components

Index description (from the official AMEX website)
The Biotechnology Index is designed to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services. 

The Index is equal-dollar weighted, designed to ensure that each of its component securities is represented in approximate equal dollar value. Equal-dollar weighting was established by designating the number of shares of each component security that represented approximately $10,000 in market value, based on closing prices on Oct. 18, 1991 (e.g., a stock that closed at $20 per share would be represented in the Index by 500 shares for a total market value of $10,000). The aggregate value of the stocks was reduced by a divisor (initially 750.1506) to establish an Index benchmark value of 200.00. 

To ensure that each component stock continues to represent approximate equal market value, adjustments are made quarterly after the close of trading on the third Friday of January, April, July and October. 

Company Name Ticker Symbol
Affymetrix, Inc AFFX
Amgen Inc. AMGN
AppleraCorp-Celera Gen Group CRA
Biogen  Inc. BGEN
Cephalon Inc. CEPH
Chiron Corporation CHIR
COR Therapeutics Inc. CORR
Genentech Inc. DNA
Genzyme Corporation GENZ
Gilead Sciences Inc. GILD
Human Genome Sciences, Inc. HGSI
IDEC Pharmaceuticals Corp. IDPH
Immunex Corporation IMNX
Medimmune Inc. MEDI
Millennium Pharmaceuticals, Inc. MLNM
Protein Design Labs Inc. PDLI
Vertex Pharmaceuticals Inc. VRTX

AFFX,AMGN,CRA,BGEN,CEPH,CHIR,CORR,DNA,GENZ,GILD,HGSI,IDPH,IMNX,MEDI,MLNM,PDLI,VRTX

Home